"Rho(D) Immune Globulin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunizing agent containing IMMUNOGLOBULIN G anti-Rho(D) used for preventing Rh immunization in Rh-negative individuals exposed to Rh-positive red blood cells.
| Descriptor ID |
D018029
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.393.700 D12.776.124.790.651.114.619.393.700 D12.776.377.715.548.114.619.393.700
|
| Concept/Terms |
Rho(D) Immune Globulin- Rho(D) Immune Globulin
- Rho(D) Immune Human Globulin
- Immune Globulin, Rh
- Anti-D-Immunoglobulin
- Anti D Immunoglobulin
- Rh Immune Globulin
- Globulin, Rh Immune
|
Below are MeSH descriptors whose meaning is more general than "Rho(D) Immune Globulin".
Below are MeSH descriptors whose meaning is more specific than "Rho(D) Immune Globulin".
This graph shows the total number of publications written about "Rho(D) Immune Globulin" by people in this website by year, and whether "Rho(D) Immune Globulin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rho(D) Immune Globulin" by people in Profiles.
-
Association of a positive direct antiglobulin test with chronic immune thrombocytopenia and use of second line therapies in children: A multi-institutional review. Am J Hematol. 2019 04; 94(4):461-466.
-
Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment. J Pediatr. 2019 01; 204:11-13.
-
Cancer type predicts alloimmunization following RhD-incompatible RBC transfusions. Transfusion. 2017 04; 57(4):952-958.
-
Circulating Cell-Free DNA to Determine the Fetal RHD Status in All Three Trimesters of Pregnancy. Obstet Gynecol. 2016 12; 128(6):1340-1346.
-
Phasing-in RHD genotyping. Arch Pathol Lab Med. 2014 May; 138(5):585-8.
-
Anti-D immunoglobulin therapy for pediatric ITP: before and after the FDA's black box warning. Pediatr Blood Cancer. 2013 Nov; 60(11):E149-51.
-
Weak D types in the Egyptian population. Am J Clin Pathol. 2013 Jun; 139(6):806-11.
-
RHD zygosity predicts degree of platelet response to anti-D immune globulin treatment in children with immune thrombocytopenia. Pediatr Blood Cancer. 2013 Sep; 60(9):E106-8.
-
An analysis of outcomes and treatment costs for children undergoing splenectomy for chronic immune thrombocytopenia purpura. J Pediatr Surg. 2012 Aug; 47(8):1537-41.
-
A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression. Am J Hematol. 2012 Mar; 87(3):266-71.